Meanwhile, breast cancer studies have identified WNK2 as a downstream target of MiR-370, which mainly exerts its oncogenic function through down-regulation of the tumor suppressor WNK2, thereby affecting cell proliferation and tumor growth [146]. The gene discussed is WNK2; the disease is neoplasm.